Skip to main content
. 2011 Jun 29;60(12):1707–1720. doi: 10.1007/s00262-011-1056-9

Fig. 6.

Fig. 6

A proposed model of aATC immunotherapy induced in vivo immunization of patient’s endogenous immune system: aATC-mediated killing of tumor cells releases cytokines and tumor antigens; cytokines secreted as a function of aATC induce maturation and activation of monocytes to become DC and Ag-primed DCs present antigen to naïve T-cells. Primed T-cell and B-cell interactions leads to B-cell proliferation and differentiation into tumor-specific antibody-producing cells